Pulmicort Flexhaler

Proteinuria, Asthma, Itching + 16 more

Treatment

20 Active Studies for Pulmicort Flexhaler

What is Pulmicort Flexhaler

Budesonide

The Generic name of this drug

Treatment Summary

Budesonide is a steroid medication used to treat inflammation in the lungs and intestines. It is commonly used to treat conditions such as asthma, chronic obstructive pulmonary disease (COPD), Crohn’s disease, and ulcerative colitis. Budesonide was approved by the FDA in 1994 and is available in various forms, such as inhalers, tablets, and suspensions.

Rhinocort

is the brand name

image of different drug pills on a surface

Pulmicort Flexhaler Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

Rhinocort

Budesonide

1994

134

Effectiveness

How Pulmicort Flexhaler Affects Patients

Budesonide is a drug used to reduce inflammation in the respiratory and digestive systems. The amount of the drug that needs to be taken varies from person to person and it is generally considered to be very safe. However, people should be aware of the potential risks of taking this drug, such as an increased level of cortisol in the body, as well as a decreased ability of the adrenal glands to produce hormones.

How Pulmicort Flexhaler works in the body

Corticosteroids are medications that reduce inflammation. They work by binding to a receptor and causing changes in gene expression. These changes result in decreased inflammation, decreased cell death, and increased production of anti-inflammatory proteins. Low doses of corticosteroids provide an anti-inflammatory effect, while higher doses are immunosuppressive, meaning they can weaken the immune system. At very high doses, corticosteroids can also affect the mineralocorticoid receptor, causing an increase in sodium levels and a decrease in potassium levels.

When to interrupt dosage

The measure of Pulmicort Flexhaler is contingent upon the diagnosed illness, including Vasomotor Rhinitis, Crohn's Disease and Chronic Obstructive Pulmonary Disease (COPD). Dosage shifts, correlative to the delivery strategy (e.g. Enema; Kit; Tablet - Rectal or Respiratory (inhalation)) specified in the following table.

Condition

Dosage

Administration

Chronic Obstructive Pulmonary Disease

, 0.25 mg/mL, 0.5 mg/mL, 1.0 mg/mL, 0.09 mg, 0.032 mg, 3.0 mg, 0.18 mg, 0.2 mg, 0.5 mg, 9.0 mg, 28.0 mg, 2.3 mg, 0.08 mg, 0.16 mg, 0.00008 mg/hour, 0.32 mg, 1.0 mg, 6.0 mg, 0.125 mg/mL, 4.0 mg, 0.064 mg/pump actuation, 0.4 mg/pump actuation, 0.1 mg/pump actuation, 2.0 mg/pump actuation, 0.2 mg/pump actuation, 0.182 mg/pump actuation

Respiratory (inhalation), Inhalant, , Inhalant - Respiratory (inhalation), Suspension, Suspension - Respiratory (inhalation), Aerosol, powder, Aerosol, powder - Respiratory (inhalation), Nasal, Spray, metered, Capsule, Spray, metered - Nasal, Oral, Capsule - Oral, Powder - Respiratory (inhalation), Powder, Aerosol, metered - Nasal, Tablet, extended release, Aerosol, foam, Aerosol, foam - Rectal, Rectal, Capsule, delayed release pellets, Tablet, extended release - Oral, Enema; Kit; Tablet, Enema; Kit; Tablet - Rectal, Capsule, extended release, Capsule, extended release - Oral, Capsule, coated pellets - Oral, Capsule, coated pellets, Nasal; Respiratory (inhalation), Aerosol - Respiratory (inhalation), Aerosol, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Inhalant - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Powder, metered, Powder, metered - Respiratory (inhalation), Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Cutaneous, Kit, Kit - Rectal, Aerosol, metered, Capsule, delayed release, Aerosol, metered - Respiratory (inhalation), Patch - Cutaneous, Patch, Powder - Nasal; Respiratory (inhalation), Capsule, delayed release - Oral, Capsule, delayed release pellets - Oral

Acute Coryza

, 0.25 mg/mL, 0.5 mg/mL, 1.0 mg/mL, 0.09 mg, 0.032 mg, 3.0 mg, 0.18 mg, 0.2 mg, 0.5 mg, 9.0 mg, 28.0 mg, 2.3 mg, 0.08 mg, 0.16 mg, 0.00008 mg/hour, 0.32 mg, 1.0 mg, 6.0 mg, 0.125 mg/mL, 4.0 mg, 0.064 mg/pump actuation, 0.4 mg/pump actuation, 0.1 mg/pump actuation, 2.0 mg/pump actuation, 0.2 mg/pump actuation, 0.182 mg/pump actuation

Respiratory (inhalation), Inhalant, , Inhalant - Respiratory (inhalation), Suspension, Suspension - Respiratory (inhalation), Aerosol, powder, Aerosol, powder - Respiratory (inhalation), Nasal, Spray, metered, Capsule, Spray, metered - Nasal, Oral, Capsule - Oral, Powder - Respiratory (inhalation), Powder, Aerosol, metered - Nasal, Tablet, extended release, Aerosol, foam, Aerosol, foam - Rectal, Rectal, Capsule, delayed release pellets, Tablet, extended release - Oral, Enema; Kit; Tablet, Enema; Kit; Tablet - Rectal, Capsule, extended release, Capsule, extended release - Oral, Capsule, coated pellets - Oral, Capsule, coated pellets, Nasal; Respiratory (inhalation), Aerosol - Respiratory (inhalation), Aerosol, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Inhalant - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Powder, metered, Powder, metered - Respiratory (inhalation), Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Cutaneous, Kit, Kit - Rectal, Aerosol, metered, Capsule, delayed release, Aerosol, metered - Respiratory (inhalation), Patch - Cutaneous, Patch, Powder - Nasal; Respiratory (inhalation), Capsule, delayed release - Oral, Capsule, delayed release pellets - Oral

Ulcerative Colitis

, 0.25 mg/mL, 0.5 mg/mL, 1.0 mg/mL, 0.09 mg, 0.032 mg, 3.0 mg, 0.18 mg, 0.2 mg, 0.5 mg, 9.0 mg, 28.0 mg, 2.3 mg, 0.08 mg, 0.16 mg, 0.00008 mg/hour, 0.32 mg, 1.0 mg, 6.0 mg, 0.125 mg/mL, 4.0 mg, 0.064 mg/pump actuation, 0.4 mg/pump actuation, 0.1 mg/pump actuation, 2.0 mg/pump actuation, 0.2 mg/pump actuation, 0.182 mg/pump actuation

Respiratory (inhalation), Inhalant, , Inhalant - Respiratory (inhalation), Suspension, Suspension - Respiratory (inhalation), Aerosol, powder, Aerosol, powder - Respiratory (inhalation), Nasal, Spray, metered, Capsule, Spray, metered - Nasal, Oral, Capsule - Oral, Powder - Respiratory (inhalation), Powder, Aerosol, metered - Nasal, Tablet, extended release, Aerosol, foam, Aerosol, foam - Rectal, Rectal, Capsule, delayed release pellets, Tablet, extended release - Oral, Enema; Kit; Tablet, Enema; Kit; Tablet - Rectal, Capsule, extended release, Capsule, extended release - Oral, Capsule, coated pellets - Oral, Capsule, coated pellets, Nasal; Respiratory (inhalation), Aerosol - Respiratory (inhalation), Aerosol, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Inhalant - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Powder, metered, Powder, metered - Respiratory (inhalation), Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Cutaneous, Kit, Kit - Rectal, Aerosol, metered, Capsule, delayed release, Aerosol, metered - Respiratory (inhalation), Patch - Cutaneous, Patch, Powder - Nasal; Respiratory (inhalation), Capsule, delayed release - Oral, Capsule, delayed release pellets - Oral

Proteinuria

, 0.25 mg/mL, 0.5 mg/mL, 1.0 mg/mL, 0.09 mg, 0.032 mg, 3.0 mg, 0.18 mg, 0.2 mg, 0.5 mg, 9.0 mg, 28.0 mg, 2.3 mg, 0.08 mg, 0.16 mg, 0.00008 mg/hour, 0.32 mg, 1.0 mg, 6.0 mg, 0.125 mg/mL, 4.0 mg, 0.064 mg/pump actuation, 0.4 mg/pump actuation, 0.1 mg/pump actuation, 2.0 mg/pump actuation, 0.2 mg/pump actuation, 0.182 mg/pump actuation

Respiratory (inhalation), Inhalant, , Inhalant - Respiratory (inhalation), Suspension, Suspension - Respiratory (inhalation), Aerosol, powder, Aerosol, powder - Respiratory (inhalation), Nasal, Spray, metered, Capsule, Spray, metered - Nasal, Oral, Capsule - Oral, Powder - Respiratory (inhalation), Powder, Aerosol, metered - Nasal, Tablet, extended release, Aerosol, foam, Aerosol, foam - Rectal, Rectal, Capsule, delayed release pellets, Tablet, extended release - Oral, Enema; Kit; Tablet, Enema; Kit; Tablet - Rectal, Capsule, extended release, Capsule, extended release - Oral, Capsule, coated pellets - Oral, Capsule, coated pellets, Nasal; Respiratory (inhalation), Aerosol - Respiratory (inhalation), Aerosol, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Inhalant - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Powder, metered, Powder, metered - Respiratory (inhalation), Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Cutaneous, Kit, Kit - Rectal, Aerosol, metered, Capsule, delayed release, Aerosol, metered - Respiratory (inhalation), Patch - Cutaneous, Patch, Powder - Nasal; Respiratory (inhalation), Capsule, delayed release - Oral, Capsule, delayed release pellets - Oral

Asthma

, 0.25 mg/mL, 0.5 mg/mL, 1.0 mg/mL, 0.09 mg, 0.032 mg, 3.0 mg, 0.18 mg, 0.2 mg, 0.5 mg, 9.0 mg, 28.0 mg, 2.3 mg, 0.08 mg, 0.16 mg, 0.00008 mg/hour, 0.32 mg, 1.0 mg, 6.0 mg, 0.125 mg/mL, 4.0 mg, 0.064 mg/pump actuation, 0.4 mg/pump actuation, 0.1 mg/pump actuation, 2.0 mg/pump actuation, 0.2 mg/pump actuation, 0.182 mg/pump actuation

Respiratory (inhalation), Inhalant, , Inhalant - Respiratory (inhalation), Suspension, Suspension - Respiratory (inhalation), Aerosol, powder, Aerosol, powder - Respiratory (inhalation), Nasal, Spray, metered, Capsule, Spray, metered - Nasal, Oral, Capsule - Oral, Powder - Respiratory (inhalation), Powder, Aerosol, metered - Nasal, Tablet, extended release, Aerosol, foam, Aerosol, foam - Rectal, Rectal, Capsule, delayed release pellets, Tablet, extended release - Oral, Enema; Kit; Tablet, Enema; Kit; Tablet - Rectal, Capsule, extended release, Capsule, extended release - Oral, Capsule, coated pellets - Oral, Capsule, coated pellets, Nasal; Respiratory (inhalation), Aerosol - Respiratory (inhalation), Aerosol, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Inhalant - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Powder, metered, Powder, metered - Respiratory (inhalation), Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Cutaneous, Kit, Kit - Rectal, Aerosol, metered, Capsule, delayed release, Aerosol, metered - Respiratory (inhalation), Patch - Cutaneous, Patch, Powder - Nasal; Respiratory (inhalation), Capsule, delayed release - Oral, Capsule, delayed release pellets - Oral

Itching

, 0.25 mg/mL, 0.5 mg/mL, 1.0 mg/mL, 0.09 mg, 0.032 mg, 3.0 mg, 0.18 mg, 0.2 mg, 0.5 mg, 9.0 mg, 28.0 mg, 2.3 mg, 0.08 mg, 0.16 mg, 0.00008 mg/hour, 0.32 mg, 1.0 mg, 6.0 mg, 0.125 mg/mL, 4.0 mg, 0.064 mg/pump actuation, 0.4 mg/pump actuation, 0.1 mg/pump actuation, 2.0 mg/pump actuation, 0.2 mg/pump actuation, 0.182 mg/pump actuation

Respiratory (inhalation), Inhalant, , Inhalant - Respiratory (inhalation), Suspension, Suspension - Respiratory (inhalation), Aerosol, powder, Aerosol, powder - Respiratory (inhalation), Nasal, Spray, metered, Capsule, Spray, metered - Nasal, Oral, Capsule - Oral, Powder - Respiratory (inhalation), Powder, Aerosol, metered - Nasal, Tablet, extended release, Aerosol, foam, Aerosol, foam - Rectal, Rectal, Capsule, delayed release pellets, Tablet, extended release - Oral, Enema; Kit; Tablet, Enema; Kit; Tablet - Rectal, Capsule, extended release, Capsule, extended release - Oral, Capsule, coated pellets - Oral, Capsule, coated pellets, Nasal; Respiratory (inhalation), Aerosol - Respiratory (inhalation), Aerosol, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Inhalant - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Powder, metered, Powder, metered - Respiratory (inhalation), Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Cutaneous, Kit, Kit - Rectal, Aerosol, metered, Capsule, delayed release, Aerosol, metered - Respiratory (inhalation), Patch - Cutaneous, Patch, Powder - Nasal; Respiratory (inhalation), Capsule, delayed release - Oral, Capsule, delayed release pellets - Oral

maintenance therapy

, 0.25 mg/mL, 0.5 mg/mL, 1.0 mg/mL, 0.09 mg, 0.032 mg, 3.0 mg, 0.18 mg, 0.2 mg, 0.5 mg, 9.0 mg, 28.0 mg, 2.3 mg, 0.08 mg, 0.16 mg, 0.00008 mg/hour, 0.32 mg, 1.0 mg, 6.0 mg, 0.125 mg/mL, 4.0 mg, 0.064 mg/pump actuation, 0.4 mg/pump actuation, 0.1 mg/pump actuation, 2.0 mg/pump actuation, 0.2 mg/pump actuation, 0.182 mg/pump actuation

Respiratory (inhalation), Inhalant, , Inhalant - Respiratory (inhalation), Suspension, Suspension - Respiratory (inhalation), Aerosol, powder, Aerosol, powder - Respiratory (inhalation), Nasal, Spray, metered, Capsule, Spray, metered - Nasal, Oral, Capsule - Oral, Powder - Respiratory (inhalation), Powder, Aerosol, metered - Nasal, Tablet, extended release, Aerosol, foam, Aerosol, foam - Rectal, Rectal, Capsule, delayed release pellets, Tablet, extended release - Oral, Enema; Kit; Tablet, Enema; Kit; Tablet - Rectal, Capsule, extended release, Capsule, extended release - Oral, Capsule, coated pellets - Oral, Capsule, coated pellets, Nasal; Respiratory (inhalation), Aerosol - Respiratory (inhalation), Aerosol, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Inhalant - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Powder, metered, Powder, metered - Respiratory (inhalation), Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Cutaneous, Kit, Kit - Rectal, Aerosol, metered, Capsule, delayed release, Aerosol, metered - Respiratory (inhalation), Patch - Cutaneous, Patch, Powder - Nasal; Respiratory (inhalation), Capsule, delayed release - Oral, Capsule, delayed release pellets - Oral

Colitis, Collagenous

, 0.25 mg/mL, 0.5 mg/mL, 1.0 mg/mL, 0.09 mg, 0.032 mg, 3.0 mg, 0.18 mg, 0.2 mg, 0.5 mg, 9.0 mg, 28.0 mg, 2.3 mg, 0.08 mg, 0.16 mg, 0.00008 mg/hour, 0.32 mg, 1.0 mg, 6.0 mg, 0.125 mg/mL, 4.0 mg, 0.064 mg/pump actuation, 0.4 mg/pump actuation, 0.1 mg/pump actuation, 2.0 mg/pump actuation, 0.2 mg/pump actuation, 0.182 mg/pump actuation

Respiratory (inhalation), Inhalant, , Inhalant - Respiratory (inhalation), Suspension, Suspension - Respiratory (inhalation), Aerosol, powder, Aerosol, powder - Respiratory (inhalation), Nasal, Spray, metered, Capsule, Spray, metered - Nasal, Oral, Capsule - Oral, Powder - Respiratory (inhalation), Powder, Aerosol, metered - Nasal, Tablet, extended release, Aerosol, foam, Aerosol, foam - Rectal, Rectal, Capsule, delayed release pellets, Tablet, extended release - Oral, Enema; Kit; Tablet, Enema; Kit; Tablet - Rectal, Capsule, extended release, Capsule, extended release - Oral, Capsule, coated pellets - Oral, Capsule, coated pellets, Nasal; Respiratory (inhalation), Aerosol - Respiratory (inhalation), Aerosol, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Inhalant - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Powder, metered, Powder, metered - Respiratory (inhalation), Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Cutaneous, Kit, Kit - Rectal, Aerosol, metered, Capsule, delayed release, Aerosol, metered - Respiratory (inhalation), Patch - Cutaneous, Patch, Powder - Nasal; Respiratory (inhalation), Capsule, delayed release - Oral, Capsule, delayed release pellets - Oral

Crohn's Disease

, 0.25 mg/mL, 0.5 mg/mL, 1.0 mg/mL, 0.09 mg, 0.032 mg, 3.0 mg, 0.18 mg, 0.2 mg, 0.5 mg, 9.0 mg, 28.0 mg, 2.3 mg, 0.08 mg, 0.16 mg, 0.00008 mg/hour, 0.32 mg, 1.0 mg, 6.0 mg, 0.125 mg/mL, 4.0 mg, 0.064 mg/pump actuation, 0.4 mg/pump actuation, 0.1 mg/pump actuation, 2.0 mg/pump actuation, 0.2 mg/pump actuation, 0.182 mg/pump actuation

Respiratory (inhalation), Inhalant, , Inhalant - Respiratory (inhalation), Suspension, Suspension - Respiratory (inhalation), Aerosol, powder, Aerosol, powder - Respiratory (inhalation), Nasal, Spray, metered, Capsule, Spray, metered - Nasal, Oral, Capsule - Oral, Powder - Respiratory (inhalation), Powder, Aerosol, metered - Nasal, Tablet, extended release, Aerosol, foam, Aerosol, foam - Rectal, Rectal, Capsule, delayed release pellets, Tablet, extended release - Oral, Enema; Kit; Tablet, Enema; Kit; Tablet - Rectal, Capsule, extended release, Capsule, extended release - Oral, Capsule, coated pellets - Oral, Capsule, coated pellets, Nasal; Respiratory (inhalation), Aerosol - Respiratory (inhalation), Aerosol, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Inhalant - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Powder, metered, Powder, metered - Respiratory (inhalation), Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Cutaneous, Kit, Kit - Rectal, Aerosol, metered, Capsule, delayed release, Aerosol, metered - Respiratory (inhalation), Patch - Cutaneous, Patch, Powder - Nasal; Respiratory (inhalation), Capsule, delayed release - Oral, Capsule, delayed release pellets - Oral

Nasal Congestion

, 0.25 mg/mL, 0.5 mg/mL, 1.0 mg/mL, 0.09 mg, 0.032 mg, 3.0 mg, 0.18 mg, 0.2 mg, 0.5 mg, 9.0 mg, 28.0 mg, 2.3 mg, 0.08 mg, 0.16 mg, 0.00008 mg/hour, 0.32 mg, 1.0 mg, 6.0 mg, 0.125 mg/mL, 4.0 mg, 0.064 mg/pump actuation, 0.4 mg/pump actuation, 0.1 mg/pump actuation, 2.0 mg/pump actuation, 0.2 mg/pump actuation, 0.182 mg/pump actuation

Respiratory (inhalation), Inhalant, , Inhalant - Respiratory (inhalation), Suspension, Suspension - Respiratory (inhalation), Aerosol, powder, Aerosol, powder - Respiratory (inhalation), Nasal, Spray, metered, Capsule, Spray, metered - Nasal, Oral, Capsule - Oral, Powder - Respiratory (inhalation), Powder, Aerosol, metered - Nasal, Tablet, extended release, Aerosol, foam, Aerosol, foam - Rectal, Rectal, Capsule, delayed release pellets, Tablet, extended release - Oral, Enema; Kit; Tablet, Enema; Kit; Tablet - Rectal, Capsule, extended release, Capsule, extended release - Oral, Capsule, coated pellets - Oral, Capsule, coated pellets, Nasal; Respiratory (inhalation), Aerosol - Respiratory (inhalation), Aerosol, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Inhalant - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Powder, metered, Powder, metered - Respiratory (inhalation), Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Cutaneous, Kit, Kit - Rectal, Aerosol, metered, Capsule, delayed release, Aerosol, metered - Respiratory (inhalation), Patch - Cutaneous, Patch, Powder - Nasal; Respiratory (inhalation), Capsule, delayed release - Oral, Capsule, delayed release pellets - Oral

Eosinophilic Esophagitis

, 0.25 mg/mL, 0.5 mg/mL, 1.0 mg/mL, 0.09 mg, 0.032 mg, 3.0 mg, 0.18 mg, 0.2 mg, 0.5 mg, 9.0 mg, 28.0 mg, 2.3 mg, 0.08 mg, 0.16 mg, 0.00008 mg/hour, 0.32 mg, 1.0 mg, 6.0 mg, 0.125 mg/mL, 4.0 mg, 0.064 mg/pump actuation, 0.4 mg/pump actuation, 0.1 mg/pump actuation, 2.0 mg/pump actuation, 0.2 mg/pump actuation, 0.182 mg/pump actuation

Respiratory (inhalation), Inhalant, , Inhalant - Respiratory (inhalation), Suspension, Suspension - Respiratory (inhalation), Aerosol, powder, Aerosol, powder - Respiratory (inhalation), Nasal, Spray, metered, Capsule, Spray, metered - Nasal, Oral, Capsule - Oral, Powder - Respiratory (inhalation), Powder, Aerosol, metered - Nasal, Tablet, extended release, Aerosol, foam, Aerosol, foam - Rectal, Rectal, Capsule, delayed release pellets, Tablet, extended release - Oral, Enema; Kit; Tablet, Enema; Kit; Tablet - Rectal, Capsule, extended release, Capsule, extended release - Oral, Capsule, coated pellets - Oral, Capsule, coated pellets, Nasal; Respiratory (inhalation), Aerosol - Respiratory (inhalation), Aerosol, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Inhalant - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Powder, metered, Powder, metered - Respiratory (inhalation), Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Cutaneous, Kit, Kit - Rectal, Aerosol, metered, Capsule, delayed release, Aerosol, metered - Respiratory (inhalation), Patch - Cutaneous, Patch, Powder - Nasal; Respiratory (inhalation), Capsule, delayed release - Oral, Capsule, delayed release pellets - Oral

Hypersensitivity

, 0.25 mg/mL, 0.5 mg/mL, 1.0 mg/mL, 0.09 mg, 0.032 mg, 3.0 mg, 0.18 mg, 0.2 mg, 0.5 mg, 9.0 mg, 28.0 mg, 2.3 mg, 0.08 mg, 0.16 mg, 0.00008 mg/hour, 0.32 mg, 1.0 mg, 6.0 mg, 0.125 mg/mL, 4.0 mg, 0.064 mg/pump actuation, 0.4 mg/pump actuation, 0.1 mg/pump actuation, 2.0 mg/pump actuation, 0.2 mg/pump actuation, 0.182 mg/pump actuation

Respiratory (inhalation), Inhalant, , Inhalant - Respiratory (inhalation), Suspension, Suspension - Respiratory (inhalation), Aerosol, powder, Aerosol, powder - Respiratory (inhalation), Nasal, Spray, metered, Capsule, Spray, metered - Nasal, Oral, Capsule - Oral, Powder - Respiratory (inhalation), Powder, Aerosol, metered - Nasal, Tablet, extended release, Aerosol, foam, Aerosol, foam - Rectal, Rectal, Capsule, delayed release pellets, Tablet, extended release - Oral, Enema; Kit; Tablet, Enema; Kit; Tablet - Rectal, Capsule, extended release, Capsule, extended release - Oral, Capsule, coated pellets - Oral, Capsule, coated pellets, Nasal; Respiratory (inhalation), Aerosol - Respiratory (inhalation), Aerosol, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Inhalant - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Powder, metered, Powder, metered - Respiratory (inhalation), Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Cutaneous, Kit, Kit - Rectal, Aerosol, metered, Capsule, delayed release, Aerosol, metered - Respiratory (inhalation), Patch - Cutaneous, Patch, Powder - Nasal; Respiratory (inhalation), Capsule, delayed release - Oral, Capsule, delayed release pellets - Oral

IGA Glomerulonephritis

, 0.25 mg/mL, 0.5 mg/mL, 1.0 mg/mL, 0.09 mg, 0.032 mg, 3.0 mg, 0.18 mg, 0.2 mg, 0.5 mg, 9.0 mg, 28.0 mg, 2.3 mg, 0.08 mg, 0.16 mg, 0.00008 mg/hour, 0.32 mg, 1.0 mg, 6.0 mg, 0.125 mg/mL, 4.0 mg, 0.064 mg/pump actuation, 0.4 mg/pump actuation, 0.1 mg/pump actuation, 2.0 mg/pump actuation, 0.2 mg/pump actuation, 0.182 mg/pump actuation

Respiratory (inhalation), Inhalant, , Inhalant - Respiratory (inhalation), Suspension, Suspension - Respiratory (inhalation), Aerosol, powder, Aerosol, powder - Respiratory (inhalation), Nasal, Spray, metered, Capsule, Spray, metered - Nasal, Oral, Capsule - Oral, Powder - Respiratory (inhalation), Powder, Aerosol, metered - Nasal, Tablet, extended release, Aerosol, foam, Aerosol, foam - Rectal, Rectal, Capsule, delayed release pellets, Tablet, extended release - Oral, Enema; Kit; Tablet, Enema; Kit; Tablet - Rectal, Capsule, extended release, Capsule, extended release - Oral, Capsule, coated pellets - Oral, Capsule, coated pellets, Nasal; Respiratory (inhalation), Aerosol - Respiratory (inhalation), Aerosol, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Inhalant - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Powder, metered, Powder, metered - Respiratory (inhalation), Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Cutaneous, Kit, Kit - Rectal, Aerosol, metered, Capsule, delayed release, Aerosol, metered - Respiratory (inhalation), Patch - Cutaneous, Patch, Powder - Nasal; Respiratory (inhalation), Capsule, delayed release - Oral, Capsule, delayed release pellets - Oral

Skin Diseases

, 0.25 mg/mL, 0.5 mg/mL, 1.0 mg/mL, 0.09 mg, 0.032 mg, 3.0 mg, 0.18 mg, 0.2 mg, 0.5 mg, 9.0 mg, 28.0 mg, 2.3 mg, 0.08 mg, 0.16 mg, 0.00008 mg/hour, 0.32 mg, 1.0 mg, 6.0 mg, 0.125 mg/mL, 4.0 mg, 0.064 mg/pump actuation, 0.4 mg/pump actuation, 0.1 mg/pump actuation, 2.0 mg/pump actuation, 0.2 mg/pump actuation, 0.182 mg/pump actuation

Respiratory (inhalation), Inhalant, , Inhalant - Respiratory (inhalation), Suspension, Suspension - Respiratory (inhalation), Aerosol, powder, Aerosol, powder - Respiratory (inhalation), Nasal, Spray, metered, Capsule, Spray, metered - Nasal, Oral, Capsule - Oral, Powder - Respiratory (inhalation), Powder, Aerosol, metered - Nasal, Tablet, extended release, Aerosol, foam, Aerosol, foam - Rectal, Rectal, Capsule, delayed release pellets, Tablet, extended release - Oral, Enema; Kit; Tablet, Enema; Kit; Tablet - Rectal, Capsule, extended release, Capsule, extended release - Oral, Capsule, coated pellets - Oral, Capsule, coated pellets, Nasal; Respiratory (inhalation), Aerosol - Respiratory (inhalation), Aerosol, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Inhalant - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Powder, metered, Powder, metered - Respiratory (inhalation), Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Cutaneous, Kit, Kit - Rectal, Aerosol, metered, Capsule, delayed release, Aerosol, metered - Respiratory (inhalation), Patch - Cutaneous, Patch, Powder - Nasal; Respiratory (inhalation), Capsule, delayed release - Oral, Capsule, delayed release pellets - Oral

Rhinitis, Vasomotor

, 0.25 mg/mL, 0.5 mg/mL, 1.0 mg/mL, 0.09 mg, 0.032 mg, 3.0 mg, 0.18 mg, 0.2 mg, 0.5 mg, 9.0 mg, 28.0 mg, 2.3 mg, 0.08 mg, 0.16 mg, 0.00008 mg/hour, 0.32 mg, 1.0 mg, 6.0 mg, 0.125 mg/mL, 4.0 mg, 0.064 mg/pump actuation, 0.4 mg/pump actuation, 0.1 mg/pump actuation, 2.0 mg/pump actuation, 0.2 mg/pump actuation, 0.182 mg/pump actuation

Respiratory (inhalation), Inhalant, , Inhalant - Respiratory (inhalation), Suspension, Suspension - Respiratory (inhalation), Aerosol, powder, Aerosol, powder - Respiratory (inhalation), Nasal, Spray, metered, Capsule, Spray, metered - Nasal, Oral, Capsule - Oral, Powder - Respiratory (inhalation), Powder, Aerosol, metered - Nasal, Tablet, extended release, Aerosol, foam, Aerosol, foam - Rectal, Rectal, Capsule, delayed release pellets, Tablet, extended release - Oral, Enema; Kit; Tablet, Enema; Kit; Tablet - Rectal, Capsule, extended release, Capsule, extended release - Oral, Capsule, coated pellets - Oral, Capsule, coated pellets, Nasal; Respiratory (inhalation), Aerosol - Respiratory (inhalation), Aerosol, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Inhalant - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Powder, metered, Powder, metered - Respiratory (inhalation), Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Cutaneous, Kit, Kit - Rectal, Aerosol, metered, Capsule, delayed release, Aerosol, metered - Respiratory (inhalation), Patch - Cutaneous, Patch, Powder - Nasal; Respiratory (inhalation), Capsule, delayed release - Oral, Capsule, delayed release pellets - Oral

Nasal Polyps

, 0.25 mg/mL, 0.5 mg/mL, 1.0 mg/mL, 0.09 mg, 0.032 mg, 3.0 mg, 0.18 mg, 0.2 mg, 0.5 mg, 9.0 mg, 28.0 mg, 2.3 mg, 0.08 mg, 0.16 mg, 0.00008 mg/hour, 0.32 mg, 1.0 mg, 6.0 mg, 0.125 mg/mL, 4.0 mg, 0.064 mg/pump actuation, 0.4 mg/pump actuation, 0.1 mg/pump actuation, 2.0 mg/pump actuation, 0.2 mg/pump actuation, 0.182 mg/pump actuation

Respiratory (inhalation), Inhalant, , Inhalant - Respiratory (inhalation), Suspension, Suspension - Respiratory (inhalation), Aerosol, powder, Aerosol, powder - Respiratory (inhalation), Nasal, Spray, metered, Capsule, Spray, metered - Nasal, Oral, Capsule - Oral, Powder - Respiratory (inhalation), Powder, Aerosol, metered - Nasal, Tablet, extended release, Aerosol, foam, Aerosol, foam - Rectal, Rectal, Capsule, delayed release pellets, Tablet, extended release - Oral, Enema; Kit; Tablet, Enema; Kit; Tablet - Rectal, Capsule, extended release, Capsule, extended release - Oral, Capsule, coated pellets - Oral, Capsule, coated pellets, Nasal; Respiratory (inhalation), Aerosol - Respiratory (inhalation), Aerosol, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Inhalant - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Powder, metered, Powder, metered - Respiratory (inhalation), Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Cutaneous, Kit, Kit - Rectal, Aerosol, metered, Capsule, delayed release, Aerosol, metered - Respiratory (inhalation), Patch - Cutaneous, Patch, Powder - Nasal; Respiratory (inhalation), Capsule, delayed release - Oral, Capsule, delayed release pellets - Oral

Sinusitis

, 0.25 mg/mL, 0.5 mg/mL, 1.0 mg/mL, 0.09 mg, 0.032 mg, 3.0 mg, 0.18 mg, 0.2 mg, 0.5 mg, 9.0 mg, 28.0 mg, 2.3 mg, 0.08 mg, 0.16 mg, 0.00008 mg/hour, 0.32 mg, 1.0 mg, 6.0 mg, 0.125 mg/mL, 4.0 mg, 0.064 mg/pump actuation, 0.4 mg/pump actuation, 0.1 mg/pump actuation, 2.0 mg/pump actuation, 0.2 mg/pump actuation, 0.182 mg/pump actuation

Respiratory (inhalation), Inhalant, , Inhalant - Respiratory (inhalation), Suspension, Suspension - Respiratory (inhalation), Aerosol, powder, Aerosol, powder - Respiratory (inhalation), Nasal, Spray, metered, Capsule, Spray, metered - Nasal, Oral, Capsule - Oral, Powder - Respiratory (inhalation), Powder, Aerosol, metered - Nasal, Tablet, extended release, Aerosol, foam, Aerosol, foam - Rectal, Rectal, Capsule, delayed release pellets, Tablet, extended release - Oral, Enema; Kit; Tablet, Enema; Kit; Tablet - Rectal, Capsule, extended release, Capsule, extended release - Oral, Capsule, coated pellets - Oral, Capsule, coated pellets, Nasal; Respiratory (inhalation), Aerosol - Respiratory (inhalation), Aerosol, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Inhalant - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Powder, metered, Powder, metered - Respiratory (inhalation), Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Cutaneous, Kit, Kit - Rectal, Aerosol, metered, Capsule, delayed release, Aerosol, metered - Respiratory (inhalation), Patch - Cutaneous, Patch, Powder - Nasal; Respiratory (inhalation), Capsule, delayed release - Oral, Capsule, delayed release pellets - Oral

Crohn Disease

, 0.25 mg/mL, 0.5 mg/mL, 1.0 mg/mL, 0.09 mg, 0.032 mg, 3.0 mg, 0.18 mg, 0.2 mg, 0.5 mg, 9.0 mg, 28.0 mg, 2.3 mg, 0.08 mg, 0.16 mg, 0.00008 mg/hour, 0.32 mg, 1.0 mg, 6.0 mg, 0.125 mg/mL, 4.0 mg, 0.064 mg/pump actuation, 0.4 mg/pump actuation, 0.1 mg/pump actuation, 2.0 mg/pump actuation, 0.2 mg/pump actuation, 0.182 mg/pump actuation

Respiratory (inhalation), Inhalant, , Inhalant - Respiratory (inhalation), Suspension, Suspension - Respiratory (inhalation), Aerosol, powder, Aerosol, powder - Respiratory (inhalation), Nasal, Spray, metered, Capsule, Spray, metered - Nasal, Oral, Capsule - Oral, Powder - Respiratory (inhalation), Powder, Aerosol, metered - Nasal, Tablet, extended release, Aerosol, foam, Aerosol, foam - Rectal, Rectal, Capsule, delayed release pellets, Tablet, extended release - Oral, Enema; Kit; Tablet, Enema; Kit; Tablet - Rectal, Capsule, extended release, Capsule, extended release - Oral, Capsule, coated pellets - Oral, Capsule, coated pellets, Nasal; Respiratory (inhalation), Aerosol - Respiratory (inhalation), Aerosol, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Inhalant - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Powder, metered, Powder, metered - Respiratory (inhalation), Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Cutaneous, Kit, Kit - Rectal, Aerosol, metered, Capsule, delayed release, Aerosol, metered - Respiratory (inhalation), Patch - Cutaneous, Patch, Powder - Nasal; Respiratory (inhalation), Capsule, delayed release - Oral, Capsule, delayed release pellets - Oral

Crohn Disease

, 0.25 mg/mL, 0.5 mg/mL, 1.0 mg/mL, 0.09 mg, 0.032 mg, 3.0 mg, 0.18 mg, 0.2 mg, 0.5 mg, 9.0 mg, 28.0 mg, 2.3 mg, 0.08 mg, 0.16 mg, 0.00008 mg/hour, 0.32 mg, 1.0 mg, 6.0 mg, 0.125 mg/mL, 4.0 mg, 0.064 mg/pump actuation, 0.4 mg/pump actuation, 0.1 mg/pump actuation, 2.0 mg/pump actuation, 0.2 mg/pump actuation, 0.182 mg/pump actuation

Respiratory (inhalation), Inhalant, , Inhalant - Respiratory (inhalation), Suspension, Suspension - Respiratory (inhalation), Aerosol, powder, Aerosol, powder - Respiratory (inhalation), Nasal, Spray, metered, Capsule, Spray, metered - Nasal, Oral, Capsule - Oral, Powder - Respiratory (inhalation), Powder, Aerosol, metered - Nasal, Tablet, extended release, Aerosol, foam, Aerosol, foam - Rectal, Rectal, Capsule, delayed release pellets, Tablet, extended release - Oral, Enema; Kit; Tablet, Enema; Kit; Tablet - Rectal, Capsule, extended release, Capsule, extended release - Oral, Capsule, coated pellets - Oral, Capsule, coated pellets, Nasal; Respiratory (inhalation), Aerosol - Respiratory (inhalation), Aerosol, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Inhalant - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Powder, metered, Powder, metered - Respiratory (inhalation), Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Cutaneous, Kit, Kit - Rectal, Aerosol, metered, Capsule, delayed release, Aerosol, metered - Respiratory (inhalation), Patch - Cutaneous, Patch, Powder - Nasal; Respiratory (inhalation), Capsule, delayed release - Oral, Capsule, delayed release pellets - Oral

Warnings

Pulmicort Flexhaler has five contraindications and must not be taken when experiencing any of the conditions listed in the table below.

Pulmicort Flexhaler Contraindications

Condition

Risk Level

Notes

Asthma

Do Not Combine

Severe Hepatic Impairment

Do Not Combine

Status Asthmaticus

Do Not Combine

Severe Hypersensitivity Reactions

Do Not Combine

Budesonide may interact with Pulse Frequency

Severe Hypersensitivity Reactions

Do Not Combine

Budesonide may interact with Pulse Frequency

There are 20 known major drug interactions with Pulmicort Flexhaler.

Common Pulmicort Flexhaler Drug Interactions

Drug Name

Risk Level

Description

2-Methoxyethanol

Major

The risk or severity of adverse effects can be increased when Budesonide is combined with 2-Methoxyethanol.

9-(N-methyl-L-isoleucine)-cyclosporin A

Major

The risk or severity of adverse effects can be increased when Budesonide is combined with 9-(N-methyl-L-isoleucine)-cyclosporin A.

Abatacept

Major

The risk or severity of adverse effects can be increased when Budesonide is combined with Abatacept.

Abemaciclib

Major

The metabolism of Abemaciclib can be increased when combined with Budesonide.

Abetimus

Major

The risk or severity of adverse effects can be increased when Budesonide is combined with Abetimus.

Pulmicort Flexhaler Toxicity & Overdose Risk

Taking too much corticosteroid medication can lead to an excessive amount of the hormone in the body and suppress the adrenal gland. If this happens, reduce the dosage of corticosteroids until the levels are back to normal. For mice, a 200mg oral dose is fatal for female mice, and a 400mg oral dose is fatal for male mice.

image of a doctor in a lab doing drug, clinical research

Pulmicort Flexhaler Novel Uses: Which Conditions Have a Clinical Trial Featuring Pulmicort Flexhaler?

516 active studies are assessing the potential of Pulmicort Flexhaler for treating Chronic Obstructive Pulmonary Disease (COPD), Ulcerative Colitis and Allergic conditions.

Condition

Clinical Trials

Trial Phases

Asthma

91 Actively Recruiting

Phase 1, Phase 4, Early Phase 1, Phase 2, Not Applicable, Phase 3

Itching

2 Actively Recruiting

Phase 3, Not Applicable

Chronic Obstructive Pulmonary Disease

76 Actively Recruiting

Phase 3, Phase 1, Phase 2, Not Applicable, Early Phase 1, Phase 4

Proteinuria

5 Actively Recruiting

Phase 2, Phase 3, Phase 4, Phase 1

IGA Glomerulonephritis

0 Actively Recruiting

Ulcerative Colitis

15 Actively Recruiting

Phase 3, Phase 2, Phase 1, Not Applicable, Phase 4

Sinusitis

0 Actively Recruiting

Crohn's Disease

54 Actively Recruiting

Phase 1, Phase 2, Not Applicable, Phase 3, Phase 4, Early Phase 1

Hypersensitivity

1 Actively Recruiting

Phase 4

Colitis, Collagenous

0 Actively Recruiting

Skin Diseases

0 Actively Recruiting

maintenance therapy

0 Actively Recruiting

Rhinitis, Vasomotor

0 Actively Recruiting

Eosinophilic Esophagitis

0 Actively Recruiting

Acute Coryza

0 Actively Recruiting

Crohn Disease

0 Actively Recruiting

Nasal Polyps

0 Actively Recruiting

Crohn Disease

0 Actively Recruiting

Nasal Congestion

0 Actively Recruiting

Pulmicort Flexhaler Reviews: What are patients saying about Pulmicort Flexhaler?

5

Patient Review

11/19/2011

Pulmicort Flexhaler for Asthma

I have COPD and sleep apnea, and this treatment has drastically improved my quality of life. I no longer wheeze or feel uncomfortable in my chest and throat.

5

Patient Review

7/4/2012

Pulmicort Flexhaler for Asthma

Worked immediately after the first nebulizer treatment. After 3 years of continuous shortness of breath + constant migraines, I can finally breathe normally again. It took 4 pulmonologists to figure my diagnosis out, but it was worth it in the end!

5

Patient Review

4/17/2014

Pulmicort Flexhaler for Asthma

I've used Pulmicort for 20 years to manage my asthma, and it's been great! I'm able to go without it during seasons when my asthma is less active. I only use one puff daily most of the year, and can't remember the last time I needed my rescue inhaler.

5

Patient Review

3/26/2014

Pulmicort Flexhaler for Asthma

After years of struggling to breathe, this drug has allowed me to live a normal life again. I am so grateful for its existence.

5

Patient Review

5/7/2010

Pulmicort Flexhaler for Severe Chronic Obstructed Lung Disease

5

Patient Review

10/19/2010

Pulmicort Flexhaler for Asthma

5

Patient Review

3/3/2014

Pulmicort Flexhaler for Asthma Prevention

Unfortunately, this treatment didn't help my cough or breathing problems at all.

4.3

Patient Review

9/16/2012

Pulmicort Flexhaler for Severe Chronic Obstructed Lung Disease

I'm 60 years old and have been using Pulmicort for about 23 years. I just had my first DEXA scan to check for bone loss, and the results were not good. The technician said that Pulmicort can cause bone loss, and once it happens, there is no reversing it without adding more drugs into the mix (which comes with its own risks). So I'm getting off of Pulmicort as soon as possible. If you're thinking about using this medication, please do your research on the potential side effects first.

4.3

Patient Review

9/4/2015

Pulmicort Flexhaler for Asthma

WARNING! I'm 64 and have severe osteoporosis in my lower back and hips because of the Pulmicort. One asthma doctor warned me to stop taking it about four years ago, but the damage is irreversible.

3.7

Patient Review

12/27/2012

Pulmicort Flexhaler for Severe Chronic Obstructed Lung Disease

I'm dieting and exercising, but I haven't seen any results. I think the inhaler might be to blame.

3.7

Patient Review

9/15/2012

Pulmicort Flexhaler for Severe Chronic Obstructed Lung Disease

My son used this with great success and no negative effects!

3.3

Patient Review

12/9/2014

Pulmicort Flexhaler for Asthma

This drug has helped with my asthma, but unfortunately comes with the side effect of vaginal bleeding. As soon as I stop taking it, the bleeding stops; so, there's no doubt in my mind that this is the cause.

3

Patient Review

11/23/2011

Pulmicort Flexhaler for Asthma

I'm a 59-year-old woman who started vaginal bleeding after two weeks of taking this medication. I was also given Xopenex HFA, so I'm not sure which is the cause. The bleeding eased off and then stopped, but then it started again. Has anyone else had this experience? My doctor says it's not a side effect.

3

Patient Review

12/31/2012

Pulmicort Flexhaler for Severe Chronic Obstructed Lung Disease

I had been using Pulmicort through a nebulizer, but I told my consultant last month that I didn't think it was effective. He said it was more of a "placebo" effect, which didn't sit well with me.

3

Patient Review

10/19/2010

Pulmicort Flexhaler for Asthma

2.7

Patient Review

7/18/2012

Pulmicort Flexhaler for Severe Chronic Obstructed Lung Disease

One hour after taking the medication, I started feeling really sick. I threw up my dinner, got chills and felt like I was going to faint. My throat felt weird and I had a terrible taste in my mouth.

2.3

Patient Review

9/24/2013

Pulmicort Flexhaler for Severe Chronic Obstructed Lung Disease

I'm a bit confused about how to use this properly. I lost the directions, and the instructions from my doctor differed from what was written on the patient information pamphlet.

2

Patient Review

7/26/2011

Pulmicort Flexhaler for Asthma

1

Patient Review

10/22/2016

Pulmicort Flexhaler for Asthma

This flexhaler is really complicated and not user friendly. I needed to go back to the doctor just to figure out how to use it, which defeats the purpose of having a medication you can take at home.
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about pulmicort flexhaler

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the Pulmicort Flexhaler used for?

"Pulmicort Flexhaler is a powder inhaled corticosteroid used to treat and prevent symptoms of asthma in adults and children aged 6 and over."

Answered by AI

How often do you use Pulmicort Flexhaler?

"People usually take Pulmicort Flexhaler twice a day, once in the morning and once at night. If you are using Pulmicort Flexhaler, your doctor will let you know how many puffs you need to take for each dose."

Answered by AI

Is Pulmicort Flexhaler a steroid?

"Pulmicort Flexhaler is a type of inhaler that contains a powder form of the steroid budesonide. It is used to prevent asthma attacks by helping to reduce inflammation in the airways."

Answered by AI

What is the difference between Pulmicort and Pulmicort Flexhaler?

"Pulmicort is a good option for controlling and preventing asthma symptoms in children, but it is not a rescue inhaler and requires a jet nebulizer machine. The most effective class of medicines for managing asthma is inhaled corticosteroids, and Pulmicort Flexhaler is a good option for this."

Answered by AI

Clinical Trials for Pulmicort Flexhaler

Image of Johns Hopkins University School of Medicine in Baltimore, United States.

N-Acetylglucosamine for Crohn's Disease

13 - 80
All Sexes
Baltimore, MD

This study is a clinical trial of oral N-acetylglucosamine (GlcNAc) in patients with Crohn's disease (CD). This study includes two study groups divided by gene variation in a transporter protein that regulates manganese levels. This genetic variant increases the risk of Crohn's disease (especially involving the ileum) and is carried by approximately 10% of individuals with Crohn's disease. This genetic variant lowers manganese levels, and manganese is important in a cellular process called glycosylation, therefore, glycosylation is changed. Glycosylation in the gut controls the barrier function, interactions with the bugs in the gut, and immune function - all important in Crohn's disease. In this study, the investigators will test if this problem with glycosylation can be targeted by giving GlcNAc. GlcNAc is a key ingredient for glycosylation, and it is currently marketed as a dietary supplement in the United States.

Phase 2
Waitlist Available

Johns Hopkins University School of Medicine

Joanna Melia, MD

Have you considered Pulmicort Flexhaler clinical trials?

We made a collection of clinical trials featuring Pulmicort Flexhaler, we think they might fit your search criteria.
Go to Trials

Have you considered Pulmicort Flexhaler clinical trials?

We made a collection of clinical trials featuring Pulmicort Flexhaler, we think they might fit your search criteria.
Go to Trials
Image of Precision Clinical Research-Site Number: 8400059 in Coral Springs, United States.

Duvakitug for Crohn's Disease

16 - 80
All Sexes
Coral Springs, FL

This is a multicenter, randomized, double-blind, placebo-controlled, maintenance, Phase 3 study to evaluate the efficacy and safety of duvakitug in participants with moderately to severely active Crohn's Disease (CD). Study details include: The study duration may be up to 286 weeks including: * 40-week Pivotal Maintenance Sub-Study * 240-week Open-Label Extension (OLE) Sub-Study * 45-day Follow-Up visit Note: For the participants who do not enroll into OLE Sub-Study, the duration will be up to 46 weeks, including the 40-week maintenance period and a 45-day follow-up visit. The treatment duration may be up to 280 weeks including: * 40 weeks in the Pivotal Maintenance Sub-Study * 240 weeks in OLE Sub-Study The total number of on-site visits will be up to 43: - 21 visits in the Pivotal Maintenance Sub-Study - 22 visits in the OLE Sub-Study

Phase 3
Recruiting

Precision Clinical Research-Site Number: 8400059 (+2 Sites)

Sanofi

Image of Precision Clinical Research-Site Number: 8400059 in Coral Springs, United States.

Duvakitug for Crohn's Disease

16 - 80
All Sexes
Coral Springs, FL

This is a multinational, multicenter, randomized, double-blind, placebo-controlled, Phase 3 induction study, comprised of 3 sub-studies, to evaluate the efficacy and safety of duvakitug in participants with moderately to severely active CD. Study details include: The study duration may be up to 35 weeks with: * Up to 5-week Screening Period. * 12-week Sub-Study 1 (Single Arm Open-Label Feeder Induction) or Sub-Study 2 (Pivotal Induction). * 12-week Sub-Study 3 (Extended Induction for non-responders). * 6 weeks (45 days) follow-up period for participants who do not enroll into the Pivotal Maintenance Study (EFC18327). The treatment duration will be up to 12 weeks in each sub-study. The number of scheduled study visits for participants who continue to the Pivotal Maintenance Study (EFC18327) will be up to 8 (Sub-Study 1 and Sub-Study 2) and up to 15 for participants who enroll in Sub-Study 3.

Phase 3
Recruiting

Precision Clinical Research-Site Number: 8400059 (+30 Sites)

Sanofi

Image of Victoria Hospital - London Health Sciences Centre in London, Canada.

Vitamin D for Inflammatory Bowel Disease

18 - 85
All Sexes
London, Canada

The aim of this clinical trial is to gain a better understanding of the effect of Vitamin D supplementation on disease activity and overall health. The main questions it aims to answer are: 1. What proportion of IBD patients adhere to Vitamin D supplement recommendations over a 12-month period? 2. Is the ASK-12 Questionnaire valid in measuring adherence among IBD patients? 3. Does the severity of a patient's Crohn's disease effect overall adherence, over a 12-month period? 4. Does the severity of a patient's Ulcerative Colitis disease effect overall adherence, over a 12-month period? 5. Does Vitamin D supplementation affect the health-related Quality of Life for IBD patients? 6. Is 2,000 IU/Day an effective dose to sustain appropriate blood Vitamin D levels among previously Vitamin deficient IBD patients? Participants will: * Take 2000 IU of Vitamin D every day for the next 12 months * Complete 2 surveys, bloodwork and a fecal calprotectin test at the initial, visit, 6 month follow up and 12 month follow up

Phase 1
Waitlist Available

Victoria Hospital - London Health Sciences Centre

Terry Ponich, MD

Have you considered Pulmicort Flexhaler clinical trials?

We made a collection of clinical trials featuring Pulmicort Flexhaler, we think they might fit your search criteria.
Go to Trials